Skip to main content
Table of Contents
Print

Can Cannabis Assist with Postnatal Depression? 

Author: Dr. Clarissa Morton, PharmD

The potential of cannabis for postnatal depression is a sensitive and complex subject. Postnatal depression affects many new mothers, bringing symptoms of low mood, fatigue and difficulty bonding with their baby. Some have wondered whether cannabis, known for its calming and mood-supporting effects, could provide relief in this context. 

However, questions of treatment safety and risks during the postnatal period remain significant. Concerns about infant exposure, particularly during breastfeeding considerations, mean cannabis use in this stage must be approached with extreme caution. 

How Cannabis May Relate to Postnatal Care 

The role of cannabis for postnatal depression is still being studied, and there are important factors that shape its potential use. 

Perinatal Mental Health 

Addressing perinatal mental health requires careful and holistic approaches. While cannabis may ease anxiety and mood issues, clinical oversight is essential. 

Breastfeeding Considerations 

During breastfeeding, safety is paramount. Breastfeeding considerations highlight the risks of passing cannabinoids to the infant, making cannabis use highly controversial. 

Treatment Safety 

Any use of cannabis in this context must prioritise treatment safety. Alternatively, evidence-backed therapies are generally preferred before considering cannabis. 

In summary, while cannabis for postnatal depression may offer theoretical benefits, concerns about treatment safety and infant wellbeing limit its current role. Professional guidance is crucial, with safer first-line therapies typically recommended. 

For guidance on exploring safe approaches to postnatal mental health support, visit providers like LeafEase for personalised consultations. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories